LCC in Italian: Resectable EGFR-mutant NSCLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.

Host: • Alfredo Addeo, MD Head of Oncology Service University Hospital Geneva

Guests: Andrea R. Filippi, MD Head of Radiation Oncology, Fondazione Istituto Nazionale dei Tumori, Milan Associate Professor, Radiation Therapy Department of Oncology, University of Milan

Piergiorgio Solli, MD, PhD Head of Thoracic Surgery IRCCS Fondazione Istituto Nazionale dei Tumori, Milan